Access cutting-edge cancer treatment through this clinical trial at a research site in Daphne. Study-provided care at no cost to qualified participants.
Access cancer specialists in Daphne at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cancer treatment provided free
TAPISTRY is a Phase II, global, multicenter, open-label, multi-cohort study designed to evaluate the safety and efficacy of targeted therapies or immunotherapy as single agents or in rational, specified combinations in participants with unresectable, locally advanced or metastatic solid tumors determined to harbor specific oncogenic genomic alterations or who are tumor mutational burden (TMB)-high as identified by a validated next-generation sequencing (NGS) assay. Participants with solid tumors
Sponsor: Hoffmann-La Roche
Check if you qualify for this cancer clinical trial in Daphne, AL
If you're searching for cancer treatment options in Daphne, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Daphne research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.